Document is current
Any future updates will be listed below
-
Authors
Clusmann, Jan
Ferber, Dyke
Wiest, Isabella C.
Schneider, Carolin V.
Brinker, Titus J.
Foersch, Sebastian
Truhn, Daniel https://orcid.org/0000-0002-9605-0728
Kather, Jakob Nikolas https://orcid.org/0000-0002-3730-5348
- License Information
-
More Information
Article History
Received: 2 July 2024
Accepted: 17 December 2024
First Online: 1 February 2025
Competing interests
: The authors declare the following competing interests: DT received honoraria for lectures by Bayer and holds shares in StratifAI GmbH, Germany. SF has received honoraria from MSD and BMS. TJB is the owner of Smart Health Heidelberg GmbH, Heidelberg, Germany, outside of the scope of the submitted work. JNK declares consulting services for Bioptimus, France; Owkin, France; DoMore Diagnostics, Norway; Panakeia, UK; AstraZeneca, UK; Mindpeak, Germany; and MultiplexDx, Slovakia. Furthermore, he holds shares in StratifAI GmbH, Germany, Synagen GmbH, Germany, and has received a research grant by GSK, and has received honoraria by AstraZeneca, Bayer, Daiichi Sankyo, Eisai, Janssen, Merck, MSD, BMS, Roche, Pfizer, and Fresenius. ICW has received honoraria from AstraZeneca. DF holds shares in Synagen GmbH, Germany. No other competing interests are declared by any of the remaining authors.
